A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in overweight/obese youth with type 1 diabetes

HIGHLIGHTS

• who: Benjamin Udoka Nwosu et al. from the Division of Pediatric Endocrinology, Department of Pediatrics, University of Massachusetts Medical have published the Article: A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0137525]. September 14, 2015 of March/20,/2015
• what: In this nine-month randomized, double blind, placebo controlled trial, the authors report a 0.4% lower HbA1c value in the metformin group compared to the placebo group.
• how: To address this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.